Expression of vascular endothelial growth factor correlates with tumor progression in gallbladder cancer

International Journal of Oncology

Volumn 12, Issue 5, 1998, Pages 1013-1018

  Okita, Satoshi ^a   Kondoh, Satoshi ^a   Shiraishi, Kei ^a   Kaino, Seiji ^a   Hatano, Satoko ^a   Okita, Kiwamu ^a  

^a YAMAGUCHI UNIVERSITY   (Japan)

Author keywords

Gallbladder cancer; Ki 67; p53; Vascular endothelial growth factor; von Willebrand factor

Indexed keywords

VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; CANCER GRADING; CANCER GROWTH; DIAGNOSTIC VALUE; FEMALE; GALLBLADDER CANCER; GROWTH REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; TUMOR BIOPSY;

EID: 0031955262     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.12.5.1013     Document Type: Article

References (39)

1. Czubayko F, Smith RV, Chung HC and Wellstein A: Tumor growth and angiogenesis induced by a secreted binding protein for fibroblast growth factors. J Biol Chem 269: 28243-28248, 1994.
2. Goto F, Goto K, Weindel K and Folkman J: Synergistic effects of vascular endothelial growth factor and basic fibroblast growth factor on the proliferation and cord formation of bovine capillary endothelial cells within collagen gels. Lab Invest 69: 508-517, 1993.
3. Yang EY and Moses HL: Transforming growth factor β1-induced changes in cell migration and angiogenesis in the chicken chorioallantoicmembrane. J Cell Biol 111: 731-741, 1990.
4. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O and Alitalo K: Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J Biol Chem 269: 6271-6274, 1994.
5. Leibovich SJ, Polverini PJ, Shepard HM, Wiseman DM, Shively V and Nuseir N: Macrophage-induced angiogenesis is mediated by tumor necrosis factor-α. Nature 329: 630-632, 1987.
6. Battegay EJ, Rupp J, Iruela-Arispe L, Sage EH and Pech M: PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF β-receptors. J Cell Biol 125: 917-928, 1994.
7. Toi M, Hoshina S, Takayanagi T and Tominaga T: Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer. Jpn J Cancer Res 85: 1045-1049, 1994.
8. Maeda K, Chung YS, Ogawa Y, Takatsuka S, Kang SM, Ogawa M, Sawada T and Sowa M: Prognostic value of vascular endothelial growth factor expression in gastric carcinoma. Cancer 77: 858-863, 1996.
9. Inoue K, Ozeki Y, Sugiyama T, Sugiura Y and Tanaka S: Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Cancer 79: 206-213, 1997.
10. Henson DE, Albores-Saavedra J and Corle D: Carcinoma of the gallbladder. Histologic types, stage of disease, grade and survival rates. Cancer 70: 1493-1497, 1992.
11. Lee CS: Differences in cell proliferating and prognostic significance of proliferating cell nuclear antigen and Ki-67 antigen immunoreactivity in in situ and invasive carcinoma of the extrahepatic biliary tract. Cancer 78: 1881-1887, 1996.
12. Albores-Saavedra J, Henson DE and Sobin LH: WHO Histological Classification of Tumors of Gallbladder and Extrahepatic Bile Ducts. Springer-Verlag, Berlin, 1991.
13. Hermanek P and Sobin LH: UICC TNM Classification of Malignant Tumors. 4th edition. Kanehara & Ltd., Tokyo, 1990.
14. Japanese Society of Biliary Surgery: General Rules for Surgical and Pathological Studies on Cancer of Biliary Tract. 3rd edition. Kanehara & Ltd., Tokyo, 1993.
15. Gimbrone MA, Leapman SB, Cotran RS and Folkman J: Tumor dormancy in vivo by prevention of neovascularization. J Exp Med 136: 261-276, 1972.
16. Folkman J: What is the evidence that tumors are angiogenesis depend. J Natl Cancer Inst 82: 4-6, 1990.
17. Millauer B, Wizigmann-Voos S, Schnurch H, Martinez R, Moller NP, Risau W and Ullrich A: High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 72: 835-846, 1993.
18. Sibuya M, Yanaguchi S, Yamane A, Ikeda T, Tojo A, Matsushima H and Sato M: Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (fit) closely related to the fms family. Oncogene 5: 519-524, 1990.
19. Vries C, Escobedo JA, Ueno H, Houck K, Ferrara N and Williams LT: The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 255: 989-991, 1992.
20. Takahashi Y, Kitadai Y, Bucana CD, Karen RC and Ellis LM: Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation of human colon cancer. Cancer Res 55: 3964-3968, 1995.
21. Holligsworth HC, Kohn EC, Steinberg SM, Rothenberg ML and Merino MJ: Tumor angiogenesis in advanced stage ovarian carcinoma. Am J Pathol 147: 33-41, 1995.
22. Tanigawa N, Amaya H, Matsumura M, Simomatsuya T, Horiuchi T, Muraoka R and Iki M: Extent of tumor vascularization correlates with prognosis and hematogenous metastasis in gastric carcinoma. Cancer Res 56: 2671-2676, 1996.
23. Graham CH, Rivers J, Robert SK, Stankiewicz KS and White WL: Extent of vascularization as a prognostic indicator in thin (<0.76 mm) malignant melanomas. Am J Pathol 144: 510-514, 1994.
24. Tanigawa N, Matsumura M, Amaya H, Kitaoka A, Simomatsuya T, Lu C, Muraoka R and Tanaka T: Tumor vascularity correlates with the prognosis of patients with esophageal squamous cell carcinoma. Cancer 79: 220-225, 1997.
25. Tanigawa N, Amaya H, Matsumura M, Lu C, Kataoka A, Matsumura K and Muraoka R: Tumor angiogenesis and mode of metastasis in patients with colorectal cancer. Cancer Res 57: 1043-1046, 1997.
26. Kamel D, Pääkkö P, Nuorva K, Vähäkangas K and Soini Y: p53 and c-erbB-2 protein expression in adenocarcinoma and epithelial dysplasiaof the gallbladder. J Pathol 170: 67-72, 1993.
27. Teh M, Wee A and Raju GC: An immunohistochemical study of p53 protein in gallbladder and extrahepatic bile duct/ampullary carcinomas. Cancer 74: 1542-1545, 1993.
28. Oohasi Y, Watanabe H, Ajioka Y and Hatakeyama K: p53 immunostaining malignant from benign lesions of the gallbladder. Pathol Int 45: 58-65, 1995.
29. Hanada K, Itoh M, Fujii K, Tsuchida A, Ooishi H and Kajiyama G: K-ras and p53 mutations in stage I gallbladder carcinoma with an anomalous junction of the pancreaticobiliary duct. Cancer 77: 452-458, 1996.
30. Sasatomi E, Tokunaga O and Miyazaki K: Spontaneous apoptosis in gallbladder carcinoma. Relationships with clinicopathologic factors, expression of E-cadherin, bcl-2 protooncogene and p53 oncosuppressor gene. Cancer 78: 2101-2110, 1996.
31. Washington K and Gottfried MR: Expression of p53 in adenocarcinoma of the gallbladder and bile ducts. Liver 16: 99-104, 1996.
32. Takei K, Watanabe H, Itoi T and Saito T: p53 and Ki-67 immunoreactivity and nuclear morphometry of carcinoma-in-adenoma and adenoma of the gallbladder. Pathol Int 46: 908-917, 1996.
33. Wistuba II, Gazdar AF, Roa I and Albores-Saavedra J: p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study. Hum Pathol 27: 360-365, 1996.
34. Ajiki T, Onoyama H, Yamamoto M, Asaka K, Fujimoto T, Maeda S and Saitoh Y: p53 protein expression and prognosis in gallbladder carcinoma and premalignant lesions. Hepatogastroenterology 43: 521-526, 1996.
35. Kieser A, Weich HA, Brandner G, Marme D and Kolch W: Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression. Oncogene 9: 963-969, 1994.
36. Mukhopadhyay D, Tsiokas L and Sukhatme VP: Wild-type p53 and v-Src exert opposing influences on human vascular endothelial growth factor gene expression. Cancer Res 55: 6161-6165, 1995.
37. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H and Folkman J: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 348: 555-557, 1990.
38. Yanase T, Tamura M and Fujita K: Inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and metastasis of human cell lines in vitro and in vivo. Cancer Res 53: 2566-2570, 1993.
39. Yamaoka M, Yamamoto T and Masaki T: Inhibition of tumor growth and metastasis of rodent tumors by the angiogenesis inhibitor o-(chloroacetyl-carbamoyl) fumagillol (TNP-470; AGM-1470). Cancer Res 53: 4262-4267, 1993.